Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2018-04-13
2019-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation
NCT01825304
Change In Diaphragmatic Thickness Predicts Extubation Success
NCT02656199
Response to Diaphragmatic Pacing in Subjects With Pompe Disease
NCT02354651
Diaphragm Atrophy and Dysfunction in Mechanical Ventilation
NCT05211661
Pediatric Diaphragm Thickness Trial
NCT04882553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After rats were ventilated with PEEP for 18 hours, it was found that adaptation of the diaphragm occurred; i.e. the number of sarcomeres were decreased. It is hypothesized that this adaptation may also occur in mechanically ventilated patients. This could lead to problems in weaning a patient off the ventilator, as PEEP is abruptly removed during a spontaneous breathing trial (SBT). This leads to a reduction in end-expiratory volume which would mean that the newly-adapted diaphragm fibers are being stretched. These stretched muscle fibers are not working at their optimal length of the force-length relation, thereby contributing to diaphragm weakness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PEEP level of 5 cmH2O
During second part of the study (MRI) Diaphragm position
PEEP: 5 cmH2O
During second part of the study (MRI)
PEEP level of 10 cmH2O
During second part of the study (MRI) Diaphragm position
PEEP: 10 cmH2O
During second part of the study (MRI)
PEEP level of 15 cmH2O
During second part of the study (MRI) Diaphragm position
PEEP: 15 cmH2O
During second part of the study (MRI)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEEP: 5 cmH2O
During second part of the study (MRI)
PEEP: 10 cmH2O
During second part of the study (MRI)
PEEP: 15 cmH2O
During second part of the study (MRI)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years
Exclusion Criteria
* History of pneumothorax or family history of primary pneumothorax
* Obesity (defined as BMI \> 30kg/m²)
* Known pregnancy
* Contraindications for the placement of a nasogastric tube (upper airway/esophageal/gastric/mouth or face pathology (e.g. recent surgery, esophageal varices, diaphragmatic hernia), nasal bleeding within the last 2 weeks or use of anticoagulants)
* Contraindications for MRI (electrical/metallic implants, claustrophobia or history in metalworking)
* Subjects who are employed at the department of intensive care adults, directly involved in the study and/or family from staff of the ICU.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amsterdam UMC, location VUmc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof.dr. L.M.A. Heunks
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leo Heunks, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC, location VUmc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VU Medical Center
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL63905.029.17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.